Incannex Healthcare Inc.

Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company focused on developing oral combination medicines and psychedelic-based therapies for chronic conditions with limited treatment options. Incannex Healthcare Inc. is currently advancing programs in obstructive sleep apnea, generalized anxiety disorder, rheumatoid arthritis, and inflammatory disorders through its research and development of cannabinoid and psychedelic pharmaceutical products. Its pipeline includes fixed-dose and synthetic oral treatments designed to target underlying biological pathways and support clinical development across sleep medicine, mental health, and inflammation. Based in Sydney, Australia, Incannex Healthcare Inc. operates as a science-led developer of novel therapeutics aimed at addressing significant unmet medical needs in modern healthcare.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Joel Bradley Latham

Employees

12

Headquarters

Melbourne, VIC, Australia

Website

www.incannex.com